75N93022F00001↗
Sri International received this contract from National Institutes of Health Niaid, National Institutes of Health: $4.06M obligated so far for health r&d services; health care services; applied research. It runs to 2027-07-20.
Key facts · data as of Oct 26, 2026
- Recipient
- Sri International
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Obligated to date
- $4.06M
- Potential value
- $6.18M
- Ends
- 2027-07-20
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.
Cite this page: SpendQuery, Award 75N93022F00001, data as of Oct 26, 2026, https://spendquery.com/award?id=CONT_AWD_75N93022F00001_7529_75N93020D00011_7529
Sri International: all federal awards · Department of Health and Human Services: spending · National Institutes of Health Niaid: what it buys · The follow-on: recompete brief
NON-CLINICAL STUDIES IN SUPPORT OF IND/NDA/BLA SUBMISSIONS
Up for re-bid: ends 2027-07-20. Recompete brief → · 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases ↗
What it is
- Product or service
- Health R&D Services; Health Care Services; Applied Research (PSC AN12)
- Industry
- Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Competition
- Full and open competition
- Pricing
- Cost plus fixed fee
- How it was bought
- Single-award IDIQ · under 75N93020D00011
- Where the work is
- San Mateo, CA · district CA-16
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
3 subawards totaling $261.8K (6.4% of what was obligated), as Sri International reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| Charles River Laboratories International, Inc. | $114.9K | 1 | MA | 2024-09-30 | 2024-09-30 |
| Dow Development Laboratories, LLC | $79.0K | 1 | CA | 2025-06-25 | 2025-06-25 |
| South Dakota State University | $67.9K | 1 | SD | 2025-09-02 | 2025-09-02 |
The largest single subawards
| Date | To | Amount | For |
|---|---|---|---|
| 2024-09-30 | Charles River Laboratories, Inc. | $114.9K | PK STUDY |
| 2025-06-25 | Dow Development Laboratories, LLC | $79.0K | CLINICAL STUDIES |
| 2025-09-02 | South Dakota State University | $67.9K | BIOANALYSIS OF DMDS AND DMTS IN BLOOD AND TISSUE SAMPLES |
Every action
3 actions since 2023-09-08. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2025-09-11 | P00003 | Administrative change | $0 | NON-CLINICAL STUDIES IN SUPPORT OF IND/NDA/BLA SUBMISSIONS |
| 2024-09-16 | P00002 | Change order | $2.13M | NON-CLINICAL STUDIES IN SUPPORT OF IND/NDA/BLA SUBMISSIONS |
| 2023-09-08 | P00001 | Change order | $1.93M | NON-CLINICAL STUDIES IN SUPPORT OF IND/NDA/BLA SUBMISSIONS |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗